47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Profit (loss) on sale | 0 | 0,3 | -∞ |
Gross profit (loss) | 0 | 0,3 | -∞ |
EBITDA | 0 | 0,3 | -∞ |
Short time liabilities | 0 | 1,3 | -∞ |
Other operating costs | 0 | 0 | -∞ |
Equity capital | 0 | 0,6 | -∞ |
Operating profit (EBIT) | 0 | 0,3 | -∞ |
Assets | 0 | 1,8 | -∞ |
Net profit (loss) | 0 | 0,3 | -∞ |
Cash | 0 | 0,3 | -∞ |
Net income from sale | 0 | 10,4 | -∞ |
Liabilities and provisions for liabilities | 0 | 1,3 | -∞ |
Working assets | 0 | 1,8 | -∞ |
Other income costs | 0 | 0 | -∞ |
Depreciation | 0 | 0 | -∞ |
% | % | p.p. | |
Profitability of capital | 61,4 | ||
Equity capital to total assets | 30,4 | ||
Gross profit margin | 3,2 | ||
EBITDA Margin | 3,3 | ||
Days | Days | Days | |
Short term commitment turnover cycle | 0 | 44 | 44 |
Current financial liquidity indicator | 1.4368046522140503 | ||
Net dept to EBITDA | -0.8131968975067139 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane